Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil

Journal of Toxicology and Environmental Health - Part A

Volumn 59, Issue 7, 2000, Pages 585-589

  Durak, İlker ^a   Karaayvaz, Muammer ^b   Kavutcu, Mustafa ^c   Büyükkoçak, Serap ^a   Öztürk, H Serdar ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER; FLUOROURACIL; GLUTATHIONE PEROXIDASE; IRON; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GUINEA PIG; HEART; NONHUMAN; OXIDATION; PEROXIDATION; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES; ANTIOXIDANTS; CATALASE; COPPER; FEMALE; FLUOROURACIL; GLUTATHIONE PEROXIDASE; GUINEA PIGS; HEART; INJECTIONS, INTRAPERITONEAL; IRON; MALONDIALDEHYDE; MYOCARDIUM; SUPEROXIDE DISMUTASE;

ANIMALIA; CAVIA; CAVIA PORCELLUS; FELIS CATUS; SUS SCROFA;

EID: 0034646934     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841000156709     Document Type: Article

References (29)

1. Aebi, H. 1974. Catalase. In Methods of enzymatic analysis, ed. H. U. Bergmeyer, pp. 673-677. New York: Academic Press.
2. Anand, A. J. 1994. Fluorouracil cardiotoxicity. Ann. Pharmacother. 28:347-348.
3. Arshad, M. A. Q., Bhadra, S., Cohen, R. M., and Subbiah, M. T. R. 1991. Plasma lipoprotein peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin. Chem. 37:1756-1758.
4. Blutters-Sawatzki, R., Grathwohl, J., Mertens, R., and Lampert, F. 1995. Severe cardiotoxicity of highdose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor). Oncology 52:291-294.
5. Cassidy, J. 1997. Iatrogenic chest pain — 5-Fluorouracil cardiotoxicity. Q. J. Med 90:305-306.
6. Dasgupta, A., and Zdunek, T. 1992. In vitro lipid peroxidation of human serum catalysed by cupric ion: Antioxidant rather than prooxidant role of ascorbate. Life Sci. 56:875-882.
7. Durak, I., Canbolat, O., Kavutcu, M., Ozturk, H. S., and Yurtarslani, Z. 1996. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J. Clin. Lab. Anal. 10:17-20.
8. Durak, I., Karabacak, H. I., Buyukkogak, S., Simen, M. Y. B., Kagmaz, M., Omeroglu, E., and Ozturk, H. S. 1998. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine: Protective effects of vitamin E and C. Nephron 78:207-211.
9. Grandi, A. M., Pinotti, G., Morandi, E., Zanzi, P., Bulgheroni, P., Guasti, L., Bertolini, A., and Venco, A. 1997. Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: A one-year follow-up study. Ann. Oncol. 8:705-708.
10. Hochster, H., Wasserheit, C., and Speyer, J. 1995. Cardiotoxicity and cardioprotection during chemotherapy. Curr. Opin. Oncol. 7:304-309.
11. Kavutcu, M., Canbolat, O., Ozturk, S., Olcay, E., Ulutepe, S., Ekinci, C., Gokhun, I. H., and Durak, I. 1996. Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: The effects of vitamins E and C. Nephron 72:269-274.
12. Kirkbright, G. F. 1980. Atomic Absorption Spectroscopy in Elemental Analysis of Biological Materials, pp. 141-145. Tech. Rep. Ser. Vienna: IAEA.
13. Kohne, C. H., Thuss-Patience, P., Friedrich, M., Daniel, P. T., Kretzschmar, A., Benter, T., Bauer, B., Dietz, R., and Dorken, B. 1998. Raltitrexed (Tomudex): An alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity. Br. J. Cancer 77:973-977.
14. Kumar, S., Gupta, R. K., and Samal, N. 1995. 5-Fluorouracil induced cardiotoxicity in albino rats. Mater. Med. Pol. 27:63-66.
15. Lowry, O., Rosebrough, N., Farr, L., and Randall, R. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 182:265-275.
16. McLachlan, S. A., Millward, M. J., Toner, G. C., Guiney, M. J., and Bishop J. F. 1994. The spectrum of 5-fluorouracil cardiotoxicity. Med. J. Aust. 161:207-209.
17. Mehmetcik, G., Toker, G., and Uysal, M. 1997. Endogenous and copper-induced peroxidation and antioxidant activity of serum in hypercholesterolemic subjects. Horm. Metab. Res. 29:63-65.
18. Meyer, C. C., Calis, K. A., Burke, L. B., Walawander, C. A., and Grasela, T. H. 1997. Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 17:729-736.
19. Millart, H., Kantelip, J. P., Platonoff, N., Descous, I., Trenque, T., Lamiable, D., and Choisy, H. 1993. Increased iron content in rat myocardium after 5-fluorouracil chronic administration. Anticancer Res. 13:779-783.
20. Mizuno, Y., Hokamura, Y., Kimura, T., Kimura, Y., Kaikita, K., and Yasue, H. 1995. A case of 5-fluo-rouracil cardiotoxicity simulating acute myocardial infarction. Japan. Circ. J. 59:303-307.
21. Paglia, D. E., and Valentine, W. N. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:158-169.
22. Pan, L., Yang, X., and Song, H. 1996. Cardiotoxicity of 5-fluorouracil. Chung Hua Fu Chan Ko Tsa Chic 31:86-89.
23. Porta, C., Morini, M., Ferrari, S., and Nastasi, G. 1998. E n doth el in-1and 5-fluorouracil-induced cardiotoxicity. Neoplasma 45:81-82.
24. Sasson, Z., Morgan, C. D., Wang, B., Thomas, G., MacKenzie, B., and Platts, M. E. 1994. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can. J. Cardiol. 10:861-864.
25. Stocks, J., Gutteri dge, J. M. C., Sharp, R. J., and Dormandy, T. L. 1974. Assay using brain homogenate for measuring the antioxidant activity of biological fluids. Clin. Sci. Mol. Med. 47:215-222.
26. Van Ye, T. M., Roza, A. M., Pieper, G. M., Jr., Henderson, J., Johnson, C. P., and Adams, M. B. 1993. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J. Surg. Res. 55:553-558.
27. Walsh, J. H. 1998. Can antioxidant enhance chemotherapy? Gastroenterology 114:235-236.
28. Weidmann, B., Jansen, W., Heider, A., and Niederle, N. 1995. 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens. Am. J. Cardiol. 75:194-195.
29. Weng, M. C., Wang, W. B., and Chao, T. Y. 1995. Cardiotoxicity related to 5-fluorouracil chemotherapy: A report of two cases. Chung Hua I Hsueh Tsa Chic (Taipei) 55:266-269.